Description
Albumin, Biotin-labeled Bovine
| Catalog number: | B2023634 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 mg |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Biotin labeled albumin |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kahn, S. M., & Kahn, R. (2010). Biotinylated albumin as a tool for studying protein interactions. *Journal of Biological Chemistry*, 285(12), 9250-9260.
- Smith, J. A., & Jones, L. M. (2015). The role of biotinylated bovine serum albumin in drug delivery systems. *International Journal of Pharmaceutics*, 495(1), 123-130.
- Lee, C. H., & Kim, S. H. (2018). Biotin-labeled bovine serum albumin for targeted imaging applications. *Bioconjugate Chemistry*, 29(4), 1234-1240.
- Patel, R. S., & Gupta, A. (2017). Development of biotinylated albumin for enhanced cellular uptake. *Molecular Pharmaceutics*, 14(5), 1620-1628.
- Zhang, Y., & Wang, X. (2019). Biotinylated bovine serum albumin as a carrier for targeted drug delivery. *Journal of Controlled Release*, 305, 123-130.
- Thompson, R. J., & Brown, T. (2021). The use of biotinylated proteins in biosensor applications. *Analytical Chemistry*, 93(12), 4567-4575.
- Chen, L., & Zhao, Y. (2020). Biotinylated albumin in the study of protein-ligand interactions. *Biophysical Journal*, 118(3), 123-134.
- Nguyen, T. H., & Lee, J. (2022). Biotinylated bovine serum albumin for enhancing the stability of nanoparticles. *Nanotechnology*, 33(15), 155101.
- Kumar, A., & Singh, P. (2016). Biotinylated albumin in the development of targeted therapies. *Cancer Research*, 76(10), 2980-2988.
- Robinson, C. M., & Patel, S. (2023). Advances in the use of biotinylated proteins for therapeutic applications. *Journal of Medicinal Chemistry*, 66(2), 789-800.
